Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households

被引:134
作者
Cowling, Benjamin J. [1 ]
Fung, Rita O. P. [1 ]
Cheng, Calvin K. Y. [1 ]
Fang, Vicky J. [1 ]
Chan, Kwok Hung [2 ]
Seto, Wing Hong [3 ]
Yung, Raymond [4 ]
Chiu, Billy [5 ]
Lee, Paco [6 ]
Uyeki, Timothy M. [7 ]
Houck, Peter M. [8 ]
Peiris, J. S. Malik [2 ]
Leung, Gabriel M. [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China
[3] Queen Mary Hosp, Hosp Authority, Hong Kong, Peoples R China
[4] Gov Hong Kong SAR, Dept Hlth, Ctr Hlth Protect, Hong Kong, Peoples R China
[5] Hong Kong Sanatorium & Hosp, Hong Kong, Peoples R China
[6] St Pauls Hosp, Hong Kong, Peoples R China
[7] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA
[8] Ctr Dis Control & Prevent, Natl Ctr Preparedness, Detect & Control Infect Dis, Div Glob Migrat & Quarantine, Seattle, WA USA
来源
PLOS ONE | 2008年 / 3卷 / 05期
关键词
D O I
10.1371/journal.pone.0002101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There are sparse data on whether non-pharmaceutical interventions can reduce the spread of influenza. We implemented a study of the feasibility and efficacy of face masks and hand hygiene to reduce influenza transmission among Hong Kong household members. Methodology/Principal Findings: We conducted a cluster randomized controlled trial of households (composed of at least 3 members) where an index subject presented with influenza-like-illness of, 48 hours duration. After influenza was confirmed in an index case by the QuickVue Influenza A+ B rapid test, the household of the index subject was randomized to 1) control or 2) surgical face masks or 3) hand hygiene. Households were visited within 36 hours, and 3, 6 and 9 days later. Nose and throat swabs were collected from index subjects and all household contacts at each home visit and tested by viral culture. The primary outcome measure was laboratory culture confirmed influenza in a household contact; the secondary outcome was clinically diagnosed influenza (by self-reported symptoms). We randomized 198 households and completed follow up home visits in 128; the index cases in 122 of those households had laboratory-confirmed influenza. There were 21 household contacts with laboratory confirmed influenza corresponding to a secondary attack ratio of 6%. Clinical secondary attack ratios varied from 5% to 18% depending on case definitions. The laboratory-based or clinical secondary attack ratios did not significantly differ across the intervention arms. Adherence to interventions was variable. Conclusions/Significance: The secondary attack ratios were lower than anticipated, and lower than reported in other countries, perhaps due to differing patterns of susceptibility, lack of significant antigenic drift in circulating influenza virus strains recently, and/or issues related to the symptomatic recruitment design. Lessons learnt from this pilot have informed changes for the main study in 2008.
引用
收藏
页数:9
相关论文
共 40 条
  • [1] AIELLO AE, 2008, AM J PUBLIC IN PRESS
  • [2] Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base
    Aledort, Julia E.
    Lurie, Nicole
    Wasserman, Jeffrey
    Bozzette, Samuel A.
    [J]. BMC PUBLIC HEALTH, 2007, 7 (1)
  • [3] Is influenza an influenza-like illness?: Clinical presentation of influenza in hospitalized patients
    Babcock, Hilary M.
    Merz, Liana R.
    Fraser, Victoria J.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (03) : 266 - 270
  • [4] Current concepts - Avian influenza A (H5N1) infection in humans
    Beigel, H
    Farrar, H
    Han, AM
    Hayden, FG
    Hyer, R
    de Jong, MD
    Lochindarat, S
    Tien, NTK
    Hien, NT
    Hien, TT
    Nicoll, A
    Touch, S
    Yuen, KY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1374 - 1385
  • [5] Bell D, 2006, EMERG INFECT DIS, V12, P81
  • [6] Bell D, 2006, EMERG INFECT DIS, V12, P88
  • [7] Does this patient have influenza?
    Call, SA
    Vollenweider, MA
    Hornung, CA
    Simel, DL
    McKinney, WP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (08): : 987 - 997
  • [8] CONSORT statement: extension to cluster randomised trials
    Campbell, MK
    Elbourne, DR
    Altman, DG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7441): : 702 - 708
  • [9] Evaluation of clinical case definitions of influenza: Detailed investigation of patients during the 1995-1996 epidemic in France
    Carrat, F
    Tachet, A
    Rouzioux, C
    Housset, B
    Valleron, AJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) : 283 - 290
  • [10] Donner A., 2010, Design and analysis of cluster randomization trials in health research